Advertisement
Akoya Biosciences, Inc.

Akoya Biosciences, Inc. (AKYA) Stock Overview

Explore Akoya Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AKYANASDAQ
HealthcareMedical - Instruments & Supplies
$1.29
$0.07(5.15%)
U.S. Market opens in 64h 45m
Advertisement

Akoya Biosciences, Inc. (AKYA)

Meyka AI Score

Z

Key Financials

Market Cap64.4M
P/E Ratio-2.69
EPS (TTM)$-0.96
ROE-27.96%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AKYA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Akoya Biosciences, Inc. (AKYA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.69 and a market capitalization of 64.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
14.16%
6-Month Change
-47.56%
Year-to-Date (YTD) Change
-46.91%
1-Year Change
-34.18%
3-Year Change
-91.41%
5-Year Change
-93.55%
All-Time (Max) Change
-93.55%

Contact Information

855 896 8401
100 Campus Drive, Marlborough, MA, 01752

Company Facts

2,050 Employees
IPO DateApr 16, 2021
CountryUS

Frequently Asked Questions